Novelos expects to submit CLR1502 IND with FDA for non-invasive tumor imaging News-Medical-Net Wed, 29 Aug 2012 01:55 AM PDT Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it is developing CLR1502 (GLOW2), a preclinical cancer-targeted optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging. | Jon Lund: Pentagon links with breast cancer raise questions The Capital Times Wed, 29 Aug 2012 01:47 AM PDT Dear Editor: While reading the opinion piece regarding Pentagon spending with the title âWhy Pentagon spends billions on breast cancer research,â I remembered reading an article in Mother Jone⦠| UK & World News: Call to maintain cancer drugs fund Crewe Chronicle Wed, 29 Aug 2012 01:33 AM PDT Tens of thousands of cancer sufferers could be denied life-extending drugs unless the Government finds a way to continue funding treatment for patients, a charity has warned. | What Do Cancer Patients Think About Exercise? The Huffington Post Wed, 29 Aug 2012 01:29 AM PDT Exercise is encouraged for cancer patients -- even if they are going through treatments. But a small new study from the Mayo Clinic suggests that some cancer patients still aren't prioritizing physical fitness, and their oncologists aren't talking to them about it. | Scientists create sperm from skin sample Daily Telegraph Wed, 29 Aug 2012 01:21 AM PDT Scientists hope a new technique to generate early stage sperm cells could help male cancer survivors become fathers. | | |
|
No comments:
Post a Comment